Nicholson will replace former CEO, Philip McSweeney, a seasoned public healthcare manager, who steps down after being in the job for 12 months. McSweeney will now join the board as a non-executive director.
WinchPharma names Lyndon Nicholson as new chief executive officer
Nicholson will replace former CEO, Philip McSweeney, a seasoned public healthcare manager, who steps down after being in the job for 12 months. McSweeney will now join the board as a non-executive director.
Tags
Related posts
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
